Clinical Trial Update: Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing docetaxel, doxorubicin, and cyclophosphamide versus vinorelbine and capecitabine as preoperative treatment for locally advanced or ope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED